The Online Investor
Home
Dividends
25 Safe Dividends
Stock Splits
Mergers & Acquisitions
Mega Mergers
Stock Buybacks
Stock Buybacks
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
IPOs
Secondary Offerings
Top 20 Large Caps
Top 20 Biggest ETFs
Insider Buying
Top 25 Low PE Ratios
Analyst Actions
25 Top Analyst Picks
Articles
CAGR Calculator
Dunnan On Dollars
10 Pot Stocks
ETF Center
Knowledge Center
Retirement Center
Advertising Opportunities
Privacy Policy
Disclaimer Statement
TECH Buyback image

Bio-Techne Corporation Buyback

OLI recorded this information on 2/1/2022

Company: Bio-Techne Corporation
Buyback: TECH buyback
$Amount Authorized: $400,000,000
Buyback Details: Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of$0.32per share for the quarter endedDecember 31, 2021. The quarterly dividend will be payableFebruary 25, 2022, to all common shareholders of record onFebruary 11, 2022. Future cash dividends will be considered by the Board of Directors on a quarterly basis. Bio-Techne also announced today that its board of directors has approved a new share repurchase program authorizing the repurchase of up to $400 million of common stock. The new share repurchase program begins February 2, 2022 and replaces the previous program. The timing and number of shares to be repurchased will depend on factors such as the share price, economic and market conditions, and corporate and regulatory requirements. The share repurchase program may be suspended, amended, or discontinued at any time and does not obligate the Company to acquire any specific dollar amount or number of shares of common stock.

Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics and cell and gene therapy. Co.'s Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications.

TECH SEC Filing Email Alerts Service

Open the TECH Page at The Online Investor »

TECH — Key Stats (updated 19 hours, 52 minutes ago)
Company Name:  Bio-Techne Corp
Stock buyback:  TECH buyback
Website:  www.bio-techne.com
Sector:  Biotechnology
Number of ETFs Holding TECH:  89
Total Market Value Held by ETFs:  $1.98B
Total Market Capitalization:  $11.55B
% of Market Cap. Held by ETFs:  17.18%
 

Open the TECH Page at The Online Investor (in a new window) »
May 4, 2024  •  6:21 AM Eastern
TECH — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree TECH Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Avg. Broker Rec.

Strong Buy (3.71 out of 4)
68th percentile
(ranked higher than approx. 68% of all stocks covered)

Analysts' Target Price:
TECH Stock Forecast

 Based on Zacks ABR data;
powered by Xignite

TECH Buyback | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.